Bird Flu :: Indonesia Bird Flu – Avian influenza ? update
The Ministry of Health in Indonesia has confirmed an additional two cases of human infection with the H5N1 avian influenza virus.
The Ministry of Health in Indonesia has confirmed an additional two cases of human infection with the H5N1 avian influenza virus.
Heavy flooding has provoked the spread of Rift Valley Fever from north-east Kenya to near Garissa in the north-west of the country, the World Health Organization warned.
The UK Department of Health has announced that free seasonal flu vaccinations will be offered to people who work in close contact with poultry, as a precautionary public health measure.
The US Food and Drug Administration (FDA) has approved a refrigerated form of FluMist, the nasal-spray influenza vaccine, which should be more convenient for providers than the current formulation, MedImmune Inc. announced.
Two Indonesians have been hospitalized in less than a week with H5N1 avian influenza infections, the country?s first in more than a month, according to news services. Indonesia?s health ministry told Bloomberg News that a 14-year-old boy who tested positive for the H5N1 virus was being treated at Persahabatan Hospital in Jakarta after showing flulike symptoms on Jan_1.
Hong Kong government officials recently announced that a wild bird found dead near a busy shopping district on Dec_31 tested positive for H5N1 avian influenza.
A preliminary study suggests there may be hope in the offing for some sufferers of chronic fatigue syndrome with a new therapy being tested by researchers at the Stanford University School of Medicine.
The Indonesian Health Ministry confirms that a 14-year-old boy has tested positive for bird flu in Indonesia, the country’s first case of the virus in almost two months. The boy, from Tangerang in West Java, was hospitalised in Jakarta after he suffered from bird-flu-like symptoms on Jan_1.
US Federal officials have announced the launch of the first clinical trial of an H5N1 avian influenza vaccine made from a piece of the virus’s DNA rather than from the whole virus, an approach that may facilitate faster vaccine production.
The US HHS Secretary Mike Leavitt announced that the Department has awarded a $102.6 million, four-year contract to BioCryst Pharmaceuticals, Inc. for advanced development of their influenza antiviral drug, peramivir.